Recent clinical trials evaluating benefit of drug therapy for modification of HDL cholesterol
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine
Reference23 articles.
1. Molecular regulation of HDL metabolism and function: implications for novel therapies.;Rader;J Clin Investig,2006
2. HDL-C: role as a risk modifier.;Barter;Atheroscler Suppl,2011
3. Major lipids, apolipoproteins, and the risk of vascular disease.;Di Angelantonio;JAMA,2009
4. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90056 participants in 14 randomised trials.;Baigent;Lancet,2005
5. High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies.;Gordon;Circulation,1989
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Alcohol intake and total mortality in 142 960 individuals from the MORGAM Project: a population‐based study;Addiction;2021-07-08
2. Circulating ceramides as biomarkers of cardiovascular disease: Evidence from phenotypic and genomic studies;Atherosclerosis;2021-06
3. A Journey through Genetic Architecture and Predisposition of Coronary Artery Disease;Current Genomics;2020-09-04
4. Effects of particulate matter on atherosclerosis: a link via high-density lipoprotein (HDL) functionality?;Particle and Fibre Toxicology;2020-08-04
5. Clinical, Demographic, and Biochemical Characteristics of Patients with Acute ST-Segment Elevation Myocardial Infarction: An Analysis of Acute Coronary Syndrome Registry Data of a Single Medical Center from 2005 to 2016;ACTA CARDIOL SIN;2020
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3